Trappin-2/Elafin/Skalp Antibody (101) [DyLight 755]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-90071IR
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ELISA
Label
DyLight 755 (Excitation = 754 nm, Emission = 776 nm)
Antibody Source
Recombinant Monoclonal Rabbit IgG Clone # 101
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was obtained from a rabbit immunized with purified, recombinant Human Trappin-2/Elafin/Skalp (Accession#: NP_002629.1; Met1-Gln117).
Specificity
No cross-reactivity in ELISA with: Human SLPIHuman TGM2
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG
Applications for Trappin-2/Elafin/Skalp Antibody (101) [DyLight 755]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Trappin-2/Elafin
Long Name
Elastase Inhibitor, Transglutaminase Substrate, Serine Protease
Alternate Names
Elafin, ESI, PI3, SKALP, Trappin2
Gene Symbol
PI3
Additional Trappin-2/Elafin Products
Product Documents for Trappin-2/Elafin/Skalp Antibody (101) [DyLight 755]
Product Specific Notices for Trappin-2/Elafin/Skalp Antibody (101) [DyLight 755]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...